Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Laboratory Medicine

Test Directory / EMA (eosin-5-maleimide) binding test

EMA (eosin-5-maleimide) binding test

EDTA

TestEMA (eosin-5-maleimide) binding test
Common Abbreviations
Profile
Clinical IndicationThis assay is useful in the diagnosis of Hereditary Spherocytosis (HS). The results should be interpreted alongside a FBC and morphological assessment of a peripheral blood film. Eosin 5-Maleimide is a fluorescent dye which binds covalently to band 3 protein in the red cell membrane. Analysis by flow cytometry measures the fluorescence intensity of labelled intact red cells. Indication for requesting: Investigation of a suspected case of Hereditary Spherocytosis where the FBC result and morphology are indicative, or there is a family history, and other causes of haemolysis have been ruled out.
Specimen TypeBlood
Sample TypeEDTA
Minimum Volume1mL. The patient should not have received a transfusion in the last 3 months. 1 x 3 mL
Special PrecautionsPlease discuss with Consultant Haematologists in the first instance
Stability 24 hrs. Samples must be received in the morning by the lab, Monday - Thursday, in order to dispatch to Manchester in time. Samples will be rejected by Manchester if >72 hours old.
Turnaround Time4 Days
LaboratoryManchester Royal Infirmary Immunology Dept.
Reference IntervalInterpretation will be provided on the report.
LimitationsFalse positive results may occur for a wide spectrum of clinical conditions and rare red cell disorders unrelated to cytoskeleton defects e.g. Hereditary pyropoikilocytosis, Cryohydrocytosis, Congenital dyserythropoietic anaemia, South-East Asian ovalocytosis. Therefore caution is required when a positive test result for HS is not compatible with the clinical presentation and red cell morphology.
Additional InformationExamination of a blood film for the presence of spherocytes along with a clinical history is important in the evaluation of a reduced EMA binding test result. The presence of spherocytes and a reduced Eosin 5-Maleimide binding test result is suggestive of a diagnosis of Hereditary Spherocytosis. In some patients the test may not prove to be diagnostic and a diagnosis can only be made using other methods.
York Hospital's car park.

Getting here

Chinese Poland

View all languages >

Maternity access at York Hospital - Saturday 22 February

On Saturday 22 February, 8am-6pm, there will be a temporary change of vehicle access to the maternity unit at York Hospital. Access via entrance 2 will be closed to allow essential works to be completed. 

If you are attending the maternity unit at York on this day, please drive in via the entrance for A&E (marked blue light priority).

The multi-storey car park will not be affected by this change, and any non-urgent visitors should continue to park in this area.